Assessment of cholecystokinin 2 receptor (CCK2R) in neoplastic tissue
Lung Neoplasms
Gastrointestinal Stromal Tumors
Prognosis
Receptor, Cholecystokinin B
3. Good health
Gene Expression Regulation, Neoplastic
Pancreatic Neoplasms
Neuroendocrine Tumors
03 medical and health sciences
0302 clinical medicine
Carcinoma, Non-Small-Cell Lung
Case-Control Studies
Neoplasms
Biomarkers, Tumor
Humans
Neoplasm Invasiveness
Thyroid Neoplasms
Neoplasm Metastasis
Research Paper
Neoplasm Staging
DOI:
10.18632/oncotarget.7522
Publication Date:
2016-02-20T08:12:04Z
AUTHORS (10)
ABSTRACT
// Jyoti Roy 1, 2 , Karson S. Putt 1 Domenico Coppola 3 Marino E. Leon Farah K. Khalil Barbara A. Centeno Noel Clark 4 Valerie Stark 5 David L. Morse Philip Low Center for Drug Discovery, Purdue University, West Lafayette IN 47907 USA Department of Chemistry, Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa FL 33612 Tissue Core, Imaging and Metabolism, Technology Excellence, Correspondence to: Low, e-mail: plow@purdue.edu Keywords: cholecystokinin receptor, CCK2R, CCKBR, gastrin receptor Received: October 21, 2015 Accepted: January 29, 2016 Published: February 20, ABSTRACT The expression (CCK2R, CCKBR or receptor) has been reported on a diverse range cancers such as colorectal, liver, lung, pancreatic, ovarian, stomach, thyroid numerous neuroendocrine/carcinoid tumors. Some the colorectum, pancreas have shown to overexpress CCK2R in relation normal matched tissues same organ. This overexpression led development number CCK2R-ligand targeted imaging therapeutic agents. However, no comprehensive study comparing multiple performed. Herein, we report immunohistochemical analysis cancer samples from gastrointestinal stromal tumor (GIST), hepatocellular carcinoma (HCC), non-small cell lung (NSCLC), pancreatic adenocarcinoma, against tissue esophagus, pancreas, spleen thyroid. These results show that is present nearly all tested none had was statistically greater than samples.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (35)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....